Thoratec Corporation (NASDAQ:THOR) Investor Investigation Concerning Possible Breaches Of Fiduciary Duties In Acquisition Announced

If you purchased shares of Thoratec Corporation (NASDAQ:THOR) and currently hold any of those NASDAQ:THOR shares, you have certain options and you should contact the Shareholders Foundation, Inc.

To have your information reviewed for options and to recieve notifications about this investigation, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.
Company Name(s): 
Thoratec
Affected Securities: 
NASDAQ: THOR

July 28, 2015 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of Thoratec Corporation (NASDAQ:THOR), was announced concerning whether the takeover of Thoratec Corporation by St. Jude Medical for $63.50 per share is unfair to NASDAQ:THOR stockholders.

The investigation by a law firm concerns whether certain officers and directors of Thoratec Corporation breached their fiduciary duties owed to NASDAQ:THOR investors in connection with the proposed acquisition.

On July 22, 2015, St. Jude Medical (NYSE:STJ) and Thoratec Corporation (NASDAQ:THOR) announced that the Boards of Directors of both companies have unanimously approved an agreement under which St. Jude Medical will acquire all of the outstanding shares of Thoratec for $63.50 per share in a cash transaction valued at approximately $3.4 billion, net of cash acquired.

However, the investigation concerns whether the offer is unfair to NASDAQ:THOR stockholders. More specifically, the investigation concerns whether the Thoratec Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders' best interests in connection with the proposed sale.